Glutamine and cancer: metabolism, immune microenvironment, and therapeutic targets.
- 2025-01-24
- Review
- Cell communication and signaling : CCS 23(1)
- Ding Nan
- Weiping Yao
- Luanluan Huang
- Ruiqi Liu
- Xiaoyan Chen
- Wenjie Xia
- Hailong Sheng
- Haibo Zhang
- Xiaodong Liang
- Yanwei Lu
- PubMed: 39856712
- DOI: 10.1186/s12964-024-02018-6
- Low evidence
Oral supplementation with glutamine also enhances the immune capabilities of cancer patients, improves the sensitivity to chemotherapy and radiotherapy, and improves prognosis.
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- supplementation (dose not specified in abstract)